Brainsway to collaborate in US cocaine addiction study
The US National Institute for Drug Abuse will finance the study.
2 January 11 13:50, Globes’ Correspondent
Brainsway Ltd. is collaborating with Research Foundation for Mental Hygiene Inc. and Columbia University to test the effectiveness of its Deep TMS (transcranial magnetic stimulation) in treating cocaine addiction. The US National Institute for Drug Abuse will finance the study.
Brainsway will provide the US company with the equipment needed for the study. Brainsway will retain ownership of the equipment, which will be returned when the study is completed.
The study will be a double-blind trial with a control group.
The cocaine addiction study is part of Brainsway’s strategy to conduct clinical trials to test the effectiveness of its non-invasive Deep TMS therapy on a range of neurological diseases in collaboration with leading global research institutes and medical centers.
Brainsway’s share price rose 3.5% by mid-afternoon to NIS 7.97, giving a market cap of NIS 347 million.
Published by Globes [online], Israel business news – www.globes-online.com- on January 2, 2011